Find News

Filter articles

Applied Filters

Showing 71 to 80 of 232 results

Pfizer pneumonia patent approved in blow to MSF


The Indian Patent Office has approved pharmaceutical company Pfizer’s application to patent its Prevenar 13 (pneumococcal 7-valent conjugate) drug, despite claims by Médecins Sans Frontières that it is too obvious.

BIO 2017: The success story of OmniRat


The creator of OmniRat, the first human monoclonal antibody technology based on rats, outlined the success story of the project yesterday at the 2017 BIO International Convention.

Intellia Therapeutics granted China patent for CRISPR technology


Genome editing company Intellia Therapeutics has been granted a patent from China’s State Intellectual Property Office covering the CRISPR/Cas9 technology.

WIPO reveals new plan to fight tropical diseases


The World Intellectual Property Organization’s Re:Search has launched a new five-year guide to its activities in the fight against neglected tropical diseases, malaria and tuberculosis.

WHO to make biosimilars more available in poor countries


The World Health Organization will launch a pilot project for biosimilars to make costly cancer treatments more widely available in low and middle income countries.

Sawai acquires Upsher-Smith's generic business for $1.1bn

Japan, US21-04-2017

Japan-based Sawai Pharmaceutical has agreed to buy the generic drugs business of Upsher-Smith Laboratories for nearly $1.1 billion.

Takeda sheds off-patent drugs to focus on innovation


Takeda will sell a number of its off-patent drugs, used for treatment of diabetes, hypertension and peptic ulcers, to Teva Takeda Yakuhin for ¥28.5 billion.

Monsanto loses patent and trademark dispute in India


Agriculture company Monsanto has lost a patent and trademark dispute against Indian agribusiness Nuziveedu Seeds.

Global regime for bio piracy needed urgently, says commerce secretary of India


There is an urgent need for an effective global legal regime to prevent bio piracy, according to Rita Teaotia, commerce secretary of India.

Bayer loses patent battle at Delhi High Court


Bayer has been defeated in a patent battle against India-based drugs companies Alembic Pharmaceuticals and Natco Pharma today.

Showing 71 to 80 of 232 results